HEALWELL AI Announces $16 Million Bought Deal Private Placement
TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX), a data science and AI company focused on preventative care, is pleased to announce that it has entered into an agreement pursuant to which Clarus Securities Inc. and Eight Capital, as lead underwriters and co-bookrunners, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 11,851,900 units of the Company (the “Units”), on a “bought deal” private placement basis, at a price of $1.35 per Unit (the “Issue Price”) for gross proceeds of $16,000,065 (the “Offering”).
- Each Warrant shall entitle the holder thereof to purchase one Share at an exercise price of $1.80 for a period of two (2) years following the closing of the Offering.
- The Company intends to use the net proceeds of the Offering for growth initiatives and for general corporate and working capital purposes.
- The Units may also be offered in the United States on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S.
- persons” shall have the meaning given to them in Regulation S under the U.S. Securities Act.